Incyte Corporation (INCY) Discusses mutCALR Data and Therapeutic Advances in Myeloproliferative Neoplasms at ASH Transcript

Incyte Corporation (INCY) Discusses mutCALR Data and Therapeutic Advances in Myeloproliferative Neoplasms at ASH Transcript#Incyte #Corporation #INCY #Discusses #mutCALR #Data #Therapeutic #Advances #Myeloproliferative #Neoplasms #ASH #Transcript